Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition

Autor: Marisa Dilucca, Tamara S Rodrigues, Renan V. H. de Carvalho, Djalma S. Lima-Junior, Angela K. Cruz, Dario S. Zamboni, Ricardo de Godoi Mattos Ferreira, Fausto Almeida, Alexandre L. N. Silva, Fabiani Gai Frantz, Catarina V. Horta, Marcos Michel de Souza, Patrick F. da Silva, Lucas B. Lorenzon, Lilian Motta Cantanhêde, Marcus Vinicius Gomes da Silva
Rok vydání: 2019
Předmět:
Leishmaniasis
Mucocutaneous

0301 basic medicine
MACRÓFAGOS
Inflammasomes
Interleukin-1beta
General Physics and Astronomy
Inflammasome
Mice
0302 clinical medicine
lcsh:Science
Leishmania
Multidisciplinary
integumentary system
biology
Publisher Correction
Pathogens
Signal Transduction
medicine.drug
Parasitic infection
Science
Mucocutaneous zone
Article
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
Immunity
NLR Family
Pyrin Domain-Containing 3 Protein

parasitic diseases
Autophagy
medicine
Animals
Humans
RNA Viruses
Monocytes and macrophages
Innate immune system
Macrophages
Leishmaniasis
General Chemistry
medicine.disease
biology.organism_classification
Immunity
Innate

Toll-Like Receptor 3
030104 developmental biology
TRIF
TLR3
Immunology
Parasitology
lcsh:Q
030215 immunology
Zdroj: Nature Communications, Vol 10, Iss 1, Pp 1-17 (2019)
Nature Communications
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
ISSN: 2041-1723
Popis: Leishmania RNA virus (LRV) is an important virulence factor associated with the development of mucocutaneous Leishmaniasis, a severe form of the disease. LRV-mediated disease exacerbation relies on TLR3 activation, but downstream mechanisms remain largely unexplored. Here, we combine human and mouse data to demonstrate that LRV triggers TLR3 and TRIF to induce type I IFN production, which induces autophagy. This process results in ATG5-mediated degradation of NLRP3 and ASC, thereby limiting NLRP3 inflammasome activation in macrophages. Consistent with the known restricting role of NLRP3 for Leishmania replication, the signaling pathway triggered by LRV results in increased parasite survival and disease progression. In support of this data, we find that lesions in patients infected with LRV+ Leishmania are associated with reduced inflammasome activation and the development of mucocutaneous disease. Our findings reveal the mechanisms triggered by LRV that contribute to the development of the debilitating mucocutaneous form of Leishmaniasis.
NLRP3 activation by Leishmania parasites is critical to the outcome of the disease. Here the authors show that LRV, a virus infecting Leishmania strains associated with more severe human disease, enables the parasite to suppress the inflammasome by activating type 1 interferon through TLR3, which leads to autophagy-mediated NLRP3 degradation.
Databáze: OpenAIRE